Trial Profile
Randomized, Single-blind, Placebo-controlled, Combined Single / Multiple Dose Escalation, Group Comparison Study to Investigate Safety, Tolerability, Pharmacodynamic Effect and Pharmacokinetics of BAY 85-3934 in Patients With Renal Anemia Due to CKD (Stages 3 and 4)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Molidustat (Primary)
- Indications Anaemia
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Bayer
- 04 Dec 2014 New trial record